Mike Cioffi

Senior Vice President, Clinical Solutions and Strategic Partnerships at WCG MedAvante-Prophase

Biography

Mike Cioffi brings more than 20 years of pharmaceutical industry experience to his role leading MedAvante-ProPhase’s operational business units in support of project delivery and implementing global enterprise solutions that will drive continuous improvements in efficiency, output, and quality. Before joining MedAvante-ProPhase in July 2017, he held the position External Clinical Innovation Leader at Roche, where he was responsible for developing, integrating and operationalizing strategic innovations throughout drug development. Prior to that post, he was Vice President, Project Management, Americas for the clinical research organization PRA International, leading a team of more than 200 clinical research professionals covering all therapeutic areas. He also held senior project management and operations posts at Worldwide Clinical Trials, Inc., including responsibility for overall strategy and direction of the Central Nervous System (CNS) business unit.

Notably in the area of schizophrenia, Mr. Cioffi has been involved in over 50 global schizophrenia studies in acute exacerbation of psychotic symptoms, adjunct therapy, as well as trials introducing new formulations. His work has been in both adolescent and adult populations and includes the first approved compound for adolescent schizophrenia.

Mr. Cioffi holds a B.S. degree in Biochemical Pharmacology from the State University of New York (SUNY) at Buffalo.